伪尿素合成酶1向治疗激活抗病毒免疫力以促进癌症免疫疗法
Fan Wang1, Yu Tong1, Wenyun Guo1
1State Key Laboratory of Systems Medicine for Cancer, Department of Liver Surgery, Ren Ji Hospital, Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Cell reports
|September 5, 2025
概括
伪尿素合成酶1 (PUS1) 通过抑制先天的抗病毒信号来驱动瘤免疫逃避. 通过激活dRNA传感途径,抑制PUS1或伪尿素合成可以提高抗PD-1疗法的有效性.
科学领域:
- 字体转录学
- 癌症免疫学
- 分子生物学
背景情况:
- 伪尿素是最丰富的表体转录基因修饰物,但其细胞作用在很大程度上是未知的.
- 在癌症治疗中,
- 伪尿素合成酶1 (PUS1) 在癌症进展和免疫逃避中的作用尚未被研究.
研究的目的:
- 研究PUS1在瘤免疫逃避中的作用.
- 探索向PUS1和伪尿素合成在癌症免疫治疗中的治疗潜力.
主要方法:
- 分析瘤中的PUS1表达和与进展的相关性.
- 在小鼠肝癌模型中对PUS1进行基因切除 (MYC/Trp53-/- 和化学诱导).
- 评估瘤进展,T细胞透,T细胞功能,逆转移素表达,dSRNA水平和先天免疫信号.
- 对抗PD-1疗法的PUS1减弱和5- 甲影响的评估.
主要成果:
- PUS1在瘤中过度表达,并与恶性进展有关.
- 抑制瘤生长,增强T细胞透和功能.
- 失去PUS1会增加逆转录素的表达,dSRNA水平,以及先天的抗病毒免疫激活.
- 向PUS1或伪尿素合成使瘤对抗PD-1治疗产生敏感性.
结论:
- PUS1是瘤免疫逃避的一个关键调节器.
- 针对伪尿素合成激活dRNA感应通路,增强免疫疗法.
- PUS1抑制是改善癌症免疫治疗结果的有希望的策略.
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Rous Sarcoma Virus (RSV) and Cancer
5.4K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.4K
Tumor Immunotherapy
658
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
658
Mechanisms of Retrovirus-induced Cancers
5.2K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.2K
Cancer Vaccines
509
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K


